MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 118 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $189,310 | -15.8% | 5,537 | -38.1% | 0.03% | -6.9% |
Q1 2024 | $224,874 | +41.2% | 8,952 | +66.0% | 0.03% | -6.5% |
Q4 2023 | $159,231 | +411.0% | 5,394 | +447.1% | 0.03% | +244.4% |
Q3 2023 | $31,158 | +141.9% | 986 | +98.0% | 0.01% | +125.0% |
Q2 2023 | $12,883 | +7.5% | 498 | -0.2% | 0.00% | 0.0% |
Q1 2023 | $11,986 | +64.3% | 499 | +33.4% | 0.00% | +33.3% |
Q4 2022 | $7,293 | +4.2% | 374 | +8.4% | 0.00% | 0.0% |
Q3 2022 | $7,000 | – | 345 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |